## Abstract Denosumab, a fully human monoclonal antibody to RANKL, decreases bone remodeling, increases bone density, and reduces fracture risk. This study evaluates the time course and determinants of bone turnover marker (BTM) response during denosumab treatment, the percentage of denosumabโtreat
Isotope retention for assessment of bone turnover in involutional osteoporosis
โ Scribed by M. Passeri; E. Palummeri; M. C. Baroni; F. Quaini; A. Quintavalla; M. Barbagallo; D. Franchini; D. Ugolotti
- Publisher
- Springer
- Year
- 1989
- Tongue
- English
- Weight
- 359 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0770-3198
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Changes of bone turnover with aging are responsible for bone loss and play a major role in osteoporosis. Although an increase of bone turnover has been documented at the time of menopause, the subsequent abnormalities of bone resorption and formation and their potential role in determining bone mass
In recent years there has been increasing interest in radio-epidemiological techniques to retrospectively measure the radon dose exposure by determining the activity of 210 Pb, the longest-lived 222 Rn progeny, in glass surface layers. In this study the diffusion of 39 keV 209 Pb + ions implanted in
## Abstract This randomized, doubleโblind, placeboโcontrolled, doseโresponse late phase 2 study evaluated the efficacy and safety of bazedoxifene in postmenopausal Japanese women 85 years of age or younger with osteoporosis. Eligible subjects received daily treatment with oral doses of bazedoxifene